Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Chromadex Corp CDXC

Chromadex Corp. is a global bioscience company. The Company is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. Its segments include Consumer Products, Ingredients and Analytical Reference Standards and Services. The Consumer Products segment provides finished dietary supplement products that contain the Company's proprietary ingredients, commercialized as Tru Niagen, directly to consumers and distributors. The Ingredients segment develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The Ingredients segment provides Niagen in ingredient form to its strategic partners. The Analytical Reference Standards and Services segment offers the supply of phytochemical reference standards and other research and development services.


NDAQ:CDXC - Post by User

Bullboard Posts
Post by HERO547on Dec 04, 2014 3:21pm
51 Views
Post# 23196426

Just a matter of time.

Just a matter of time.
ChromaDex® CEO to Present at The Benchmark Company, LLC's Micro Cap Discovery One-on-One Conference on Dec. 11
PR Newswire ChromaDex Corp.
3 hours ago
????
IRVINE, Calif., Dec. 4, 2014 /PRNewswire/ -- ChromaDex® Corp. (CDXC), an innovative natural products company that provides proprietary, ingredients and science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today that its CEO, Frank Jaksch, will present at The Benchmark Company, LLC's Micro Cap Discovery One-on-One Conference on Thursday, Dec. 11, 2014, located at the Palmer House Hilton in Chicago.

Mr. Jaksch will be having one-on-one meetings with institutional investors throughout the day. If you would like to schedule a one-on-one meeting, please contact your Benchmark Company, LLC salesperson.

For more information on the conference, visit https://www.benchmarkcompany.com/conference.php.

The Benchmark Company, LLC:

Headquartered in New York with 11 offices coast to coast, The Benchmark Company, LLC is an institutional brokerage firm that provides Research, Sales, Trading and Investment Banking services to public companies and their investors.

Bullboard Posts